Baxter Healthcare's (UK) infusion device for home use:
This article was originally published in Clinica
Executive Summary
Baxter Healthcare (UK) has introduced its home use Intermate XLV250 ambulatory infusion device for larger volumes, specifically designed for AIDS patients receiving Foscarnet infusion. The device features a latex-free Isoprene bladder (eliminating the risk of latex-related anaphylaxis), which is optically clearer, facilitating visibility of bladder content, Baxter says. Tubing is coiled around the top of the cap to prevent tangling. The Intermate XLV250 holds 500 ml, with an infusion rate of 250 ml per hour.
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continue, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.